David Taylor Buys Shares of Medpace Holdings, Inc. $MEDP
Key Points
- David Taylor bought Medpace Holdings, Inc. ($MEDP) stock ($1,001 - $15,000).
- The trade was disclosed by a member of the House.
- $MEDP last traded around $475.11.
David Taylor vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
David Taylor, a member of the House, bought $1,001 - $15,000 of Medpace Holdings, Inc. ($MEDP) stock on 2026-05-15, according to a periodic transaction report filed under the STOCK Act. Disclosures are filed after the trade and reflect a dollar range, not an exact amount.
Medpace Holdings, Inc. ($MEDP) Stock
Medpace Holdings, Inc. Earnings
Analysts Set New Price Targets
About Medpace Holdings, Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
See Also
This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.